Enzyme promiscuity is the ability of an enzyme to catalyse a fortuitous side reaction in addition to its main reaction. Although enzymes are remarkably specific catalysts, they can often perform side reactions in addition to their main, native catalytic activity. These promiscuous activities are usually slow relative to the main activity and are under neutral selection. Despite ordinarily being physiologically irrelevant, under new selective pressures these activities may confer a fitness benefit therefore prompting the evolution of the formerly promiscuous activity to become the new main activity. An example of this is the atrazine chlorohydrolase (atzA encoded) from Pseudomonas sp. ADP which evolved from melamine deaminase (triA encoded), which has very small promiscuous activity towards atrazine, a man-made chemical.
- 1 Introduction
- 2 Enzyme evolution
- 3 Primordial metabolism
- 4 Distribution
- 5 Homology
- 6 Degree of promiscuity
- 7 Biocatalysis
- 8 Reaction similarity
- 9 Drugs and promiscuity
- 10 See also
- 11 Footnotes
- 12 References
Enzymes are evolved to catalyse a particular reaction on a particular substrate with a high catalytic efficiency (kcat/KM, cf. Michaelis–Menten kinetics). However, in addition to this main activity, they possess other activities that are generally several orders of magnitude lower, and that are not a result of evolutionary selection and therefore do not partake in the physiology of the organism.[nb 1] This phenomenon allows new functions to be gained as the promiscuous activity could confer a fitness benefit under a new selective pressure leading to its duplication and selection as a new main activity.
Duplication and divergence
Several theoretical models exist to predict the order of duplication and specialisation events, but the actual process is more intertwined and fuzzy (§ Reconstructed enzymes below). On one hand, gene amplification results in an increase in enzyme concentration, and potentially freedom from a restrictive regulation, therefore increasing the reaction rate (v) of the promiscuous activity of the enzyme making its effects more pronounced physiologically ("gene dosage effect"). On the other, enzymes may evolve an increased secondary activity with little loss to the primary activity ("robustness") with little adaptive conflict (§ Robustness and plasticity below).
Robustness and plasticity
A study of four distinct hydrolases (human serum paraoxonase (PON1), pseudomonad phosphotriesterase (PTE), Protein tyrosine phospatase(PTP) and human carbonic anhydrase II (CAII)) has shown the main activity is "robust" towards change, whereas the promiscuous activities are weak and more "plastic". Specifically, selecting for an activity that is not the main activity (via directed evolution), does not initially diminish the main activity (hence its robustness), but greatly affects the non-selected activities (hence their plasticity).
The phosphotriesterase (PTE) from Pseudomonas diminuta was evolved to become an arylesterase (P–O to C–O hydrolase) in eighteen rounds gaining a 109 shift in specificity (ratio of KM), however most of the change occurred in the initial rounds, where the unselected vestigial PTE activity was retained and the evolved arylesterase activity grew, while in the latter rounds there was a little trade-off for the loss of the vestigial PTE activity in favour of the arylesterase activity.
This means firstly that a specialist enzyme (monofunctional) when evolved goes through a generalist stage (multifunctional), before becoming a specialist again—presumably after gene duplication according to the IAD model—and secondly that promiscuous activities are more plastic than the main activity.
The most recent and most clear cut example of enzyme evolution is the rise of bioremediating enzymes in the past 60 years. Due to the very low number of amino acid changes, these provide an excellent model to investigate enzyme evolution in nature. However, using extant enzymes to determine how the family of enzymes evolved has the drawback that the newly evolved enzyme is compared to paralogues without knowing the true identity of the ancestor before the two genes divereged. This issue can be resolved thanks to ancestral reconstruction. First proposed in 1963 by Linus Pauling and Emile Zuckerkandl, ancestral reconstruction is the inference and synthesis of a gene from the ancestral form of a group of genes, which has had a recent revival thanks to improved inference techniques and low-cost artificial gene synthesis, resulting in several ancestral enzymes—dubbed "stemzymes" by some—to be studied.
Evidence gained from reconstructed enzyme suggests that the order of the events where the novel activity is improved and the gene is duplication is not clear cut, unlike what the theoretical models of gene evolution suggest.
One study showed that the ancestral gene of the immune defence protease family in mammals had a broader specificity and a higher catalytic efficiency than the contemporary family of paralogues, whereas another study showed that the ancestral steroid receptor of vertebrates was an oestrogen receptor with slight substrate ambiguity for other hormones—indicating that these probably were not synthesised at the time.
This variability in ancestral specificity has not only been observed between different genes, but also within the same gene family. In light of the large number of paralogous fungal α-glucosidase genes with a number of specific maltose-like (maltose, turanose, maltotriose, maltulose and sucrose) and isomaltose-like (isomaltose and palatinose) substrates, a study reconstructed all key ancestors and found that the last common ancestor of the paralogues was mainly active on maltose-like substrates with only trace activity for isomaltose-like sugars, despite leading to a lineage of iso-maltose glucosidases and a lineage that further split into maltose glucosidases and iso-maltose glucosidases. Antithetically, the ancestor before the latter split had a more pronounced isomaltose-like glucosidase activity.
Roy Jensen in 1976 theorised that primordial enzymes had to be highly promiscuous in order for metabolic networks to assemble in a patchwork fashion (hence its name, the patchwork model). This primordial catalytic versatility was later lost in favour of highly catalytic specialised orthologous enzymes. As a consequence, many central-metabolic enzymes have structural homologues that diverged before the last universal common ancestor.
Promiscuity is however not only a primordial trait, in fact it is very widespread property in modern genomes. A series of experiments have been conducted to assess the distribution of promiscuous enzyme activities in E. coli. In E. coli 21 out of 104 single-gene knockouts tested (from the Keio collection) could be rescued by overexpressing a noncognate E. coli protein (using a pooled set of plasmids of the ASKA collection). The mechanisms by which the noncognate ORF could rescue the knockout can be grouped into eight categories: isozyme overexpression (homologues), substrate ambiguity, transport ambiguity (scavenging), catalytic promiscuity, metabolic flux maintenance (including overexpression of the large component of a synthase in the absence of the amine transferase subunit), pathway bypass, regulatory effects and unknown mechanisms. Similarly, overexpressing the ORF collection allowed E. coli to gain over an order of magnitude in resistance in 86 out 237 toxic environment.
Homologues are sometimes known to display promiscuity towards each other's main reactions. This crosswise promiscuity has been most studied with members of the alkaline phosphatase superfamily, which catalyse hydrolytic reaction on the sulfate, phosphonate, monophosphate, diphosphate or triphosphate ester bond of several compounds. Despite the divergence the homologues have a varying degree of reciprocal promiscuity: the differences in promiscuity are due to mechanisms involved, particularly the intermediate required.
Degree of promiscuity
Enzymes are generally in a state that is not only a compromise between stability and catalytic efficiency, but also for specificity and evolvability, the latter two dictating whether an enzyme is a generalist (highly evolvable due to large promiscuity, but low main activity) or a specialist (high main activity, poorly evolvable due to low promiscuity). Examples of these are enzymes for primary and secondary metabolism in plants (§ Plant secondary metabolism below). Other factors can come into play, for example the glycerophosphodiesterase (gpdQ) from Enterobacter aerogenes shows different values for its promiscuous activities depending on the two metal ions it binds, which is dictated by ion availability. In some cases promiscuity can be increased by relaxing the specificity of the active site by enlarging it with a single mutation as was the case of a D297G mutant of the E. coli L-Ala-D/L-Glu epimerase (ycjG) and E323G mutant of a pseudomonad muconate lactonizing enzyme II, allowing them to promiscuously catalyse the activity of O-succinylbenzoate synthase (menC). Conversely, promiscuity can be decreased as was the case of γ-humulene synthase (a sesquiterpene synthase) from Abies grandis that is known to produce 52 different sesquiterpenes from farnesyl diphosphate upon several mutations.
Studies on enzymes with broad-specificity—not promiscuous, but conceptually close—such as mammalian trypsin and chymotrypsin, and the bifunctional isopropylmalate isomerase/homoaconitase from Pyrococcus horikoshii have revealed that active site loop mobility contributes substantially to the catalytic elasticity of the enzyme.
A promiscuous activity is a non-native activity the enzyme did not evolve to do, but arises due to an accommodating conformation of the active site. However, the main activity of the enzyme is a result not only of selection towards a high catalytic rate towards a particular substrate to produce a particular product, but also to avoid the production of toxic or unnecessary products. For example, if a tRNA syntheses loaded an incorrect amino acid onto a tRNA, the resulting peptide would have unexpectedly altered properties, consequently to enhance fidelity several additional domains are present. Similar in reaction to tRNA syntheses, the first subunit of tyrocidine synthetase (tyrA) from Bacillus brevis adenylates a molecule of phenylalanine in order to use the adenyl moiety as a handle to produce tyrocidine, a cyclic non-ribosomal peptide. When the specificity of enzyme was probed, it was found that it was highly selective against natural amino acids that were not phenylalanine, but was much more tolerant towards unnatural amino acids. Specifically, most amino acids were not catalysed, whereas the next most catalysed native amino acid was the structurally similar tyrosine, but at a thousandth as much as phenylalanine, whereas several unnatural amino acids where catalysed better than tyrosine, namely D-phenylalanine, β-cyclohexyl-L-alanine, 4-amino-L-phenylalanine and L-norleucine.
One peculiar case of selected secondary activity are polymerases and restriction endonucleases, where incorrect activity is actually a result of a compromise between fidelity and evolvability. For example, for restriction endonucleases incorrect activity (star activity) is often lethal for the organism, but a small amount allows new functions to evolve against new pathogens.
Plant secondary metabolism
Plants produce a large number of secondary metabolites thanks to enzymes that, unlike those involved in primary metabolism, are less catalytically efficient but have a larger mechanistic elasticity (reaction types) and broader specificities. The liberal drift threshold (caused by the low selective pressure due the small population size) allows the fitness gain endowed by one of the products to maintain the other activities even though they may be physiologically useless.
In biocatalysis, many reactions are sought that are absent in nature. To do this, enzymes with a small promiscuous activity towards the required reaction are identified and evolved via directed evolution or rational design.
An example of a commonly evolved enzyme is ω-transaminase which can replace a ketone with a chiral amine and consequently libraries of different homologues are commercially available for rapid biomining (eg. Codexis).
Drugs and promiscuity
Whereas promiscuity is mainly studied in terms of standard enzyme kinetics, drug binding and subsequent reaction is a promiscuous activity as the enzyme catalyses an inactivating reaction towards a novel substrate it did not evolve to catalyse. This could be because of the demonstration that there are only a small number of distinct ligand binding pockets in proteins.
Mammalian xenobiotic metabolism, on the other hand, was evolved to have a broad specificity to oxidise, bind and eliminate foreign lipophilic compounds which may be toxic, such as plant alkaloids, so their ability to detoxify anthropogenic xenobiotics is an extension of this.
- Most authors refer to as promiscuous activities the non-evolved activities and not secondary activities that have been evolved. Consequently, glutathione S-transferases (GSTs) and cytochrome P450 monooxygenases (CYPs) are termed multispecific or broad-specificity enzymes. The ability to catalyse different reactions is often termed catalytic promiscuity or reaction promiscuity, whereas the ability to act upon different substrates is called substrate promiscuity or substrate ambiguity. The term latent has different meanings depending on the author, namely either referring to a promiscuous activity that arises when one or two residues are mutated or simply as a synonym for promiscuous to avoid the latter term. Promiscuity here means muddledom, not lechery —the latter is a recently gained meaning of the word.
- Srinivasan B, Marks HR, Mitra S, Smalley D, Skolnick J (May 2016). "Catalytic and substrate promiscuity: Distinct multiple chemistries catalyzed by phosphatase domain of receptor protein tyrosine phosphatase". Biochemical Journal. 473: 2165–77. doi:10.1042/BCJ20160289. PMID 27208174.
- Srinivasan, Bharath (November 2016). "Specificity vs promiscuity in potein small-molecule interactions: intellectual wrangling vs absolute truth". Southeast Enzyme Conference Newsletter. 2(11): 1.
- Khersonsky O, Tawfik DS (2010). "Enzyme promiscuity: a mechanistic and evolutionary perspective". Annual Review of Biochemistry. 79: 471–505. doi:10.1146/annurev-biochem-030409-143718. PMID 20235827.
- Scott C, Jackson CJ, Coppin CW, Mourant RG, Hilton ME, Sutherland TD, Russell RJ, Oakeshott JG (April 2009). "Catalytic improvement and evolution of atrazine chlorohydrolase". Applied and Environmental Microbiology. 75 (7): 2184–91. doi:10.1128/AEM.02634-08. PMC 2663207. PMID 19201959.
- Voordeckers K, Brown CA, Vanneste K, van der Zande E, Voet A, Maere S, Verstrepen KJ (2012). Thornton JW, ed. "Reconstruction of ancestral metabolic enzymes reveals molecular mechanisms underlying evolutionary innovation through gene duplication". PLoS Biology. 10 (12): e1001446. doi:10.1371/journal.pbio.1001446. PMC 3519909. PMID 23239941.
- Patrick WM, Quandt EM, Swartzlander DB, Matsumura I (December 2007). "Multicopy suppression underpins metabolic evolvability". Molecular Biology and Evolution. 24 (12): 2716–22. doi:10.1093/molbev/msm204. PMC 2678898. PMID 17884825.
- Aharoni A, Gaidukov L, Khersonsky O, McQ Gould S, Roodveldt C, Tawfik DS (January 2005). "The 'evolvability' of promiscuous protein functions". Nature Genetics. 37 (1): 73–6. doi:10.1038/ng1482. PMID 15568024.
- Tokuriki N, Jackson CJ, Afriat-Jurnou L, Wyganowski KT, Tang R, Tawfik DS (2012). "Diminishing returns and tradeoffs constrain the laboratory optimization of an enzyme". Nature Communications. 3: 1257. Bibcode:2012NatCo...3E1257T. doi:10.1038/ncomms2246. PMID 23212386.
- Pauling, L. and E. Zuckerkandl, Chemical Paleogenetics Molecular Restoration Studies of Extinct Forms of Life. Acta Chemica Scandinavica, 1963. 17: p. 9-&.
- Williams PD, Pollock DD, Blackburne BP, Goldstein RA (June 2006). "Assessing the accuracy of ancestral protein reconstruction methods". PLoS Computational Biology. 2 (6): e69. Bibcode:2006PLSCB...2...69W. doi:10.1371/journal.pcbi.0020069. PMC 1480538. PMID 16789817.
- Stemmer WP, Crameri A, Ha KD, Brennan TM, Heyneker HL (October 1995). "Single-step assembly of a gene and entire plasmid from large numbers of oligodeoxyribonucleotides". Gene. 164 (1): 49–53. doi:10.1016/0378-1119(95)00511-4. PMID 7590320.
- Wouters MA, Liu K, Riek P, Husain A (August 2003). "A despecialization step underlying evolution of a family of serine proteases". Molecular Cell. 12 (2): 343–54. doi:10.1016/s1097-2765(03)00308-3. PMID 14536074.
- Thornton JW (May 2004). "Resurrecting ancient genes: experimental analysis of extinct molecules" (PDF). Nature Reviews Genetics. 5 (5): 366–75. doi:10.1038/nrg1324. PMID 15143319. Archived (PDF) from the original on 2012-03-27.
- Thornton JW, Need E, Crews D (September 2003). "Resurrecting the ancestral steroid receptor: ancient origin of estrogen signaling". Science. 301 (5640): 1714–7. Bibcode:2003Sci...301.1714T. doi:10.1126/science.1086185. PMID 14500980.
- Jensen RA (1976). "Enzyme recruitment in evolution of new function". Annual Review of Microbiology. 30: 409–25. doi:10.1146/annurev.mi.30.100176.002205. PMID 791073.
- Fondi M, Brilli M, Emiliani G, Paffetti D, Fani R (2007). "The primordial metabolism: an ancestral interconnection between leucine, arginine, and lysine biosynthesis". BMC Evolutionary Biology. 7 Suppl 2: S3. doi:10.1186/1471-2148-7-S2-S3. PMC 1963480. PMID 17767731.
- Skolnick J, Gao M, Roy A, Srinivasan B, Zhou H (March 2015). "Implications of the small number of distinct ligand binding pockets in proteins for drug discovery, evolution and biochemical function". Bioorganic & Medicinal Chemistry Letters. 25 (6): 1163–70. doi:10.1016/j.bmcl.2015.01.059. PMC 4593502. PMID 25690787.
- Baba T, Ara T, Hasegawa M, Takai Y, Okumura Y, Baba M, Datsenko KA, Tomita M, Wanner BL, Mori H (2006). "Construction of Escherichia coli K-12 in-frame, single-gene knockout mutants: the Keio collection". Molecular Systems Biology. 2: 2006.0008. doi:10.1038/msb4100050. PMC 1681482. PMID 16738554.
- Kitagawa M, Ara T, Arifuzzaman M, Ioka-Nakamichi T, Inamoto E, Toyonaga H, Mori H (2006). "Complete set of ORF clones of Escherichia coli ASKA library (a complete set of E. coli K-12 ORF archive): unique resources for biological research". DNA Research. 12 (5): 291–9. doi:10.1093/dnares/dsi012. PMID 16769691.
- Soo VW, Hanson-Manful P, Patrick WM (January 2011). "Artificial gene amplification reveals an abundance of promiscuous resistance determinants in Escherichia coli". Proceedings of the National Academy of Sciences of the United States of America. 108 (4): 1484–9. Bibcode:2011PNAS..108.1484S. doi:10.1073/pnas.1012108108. PMC 3029738. PMID 21173244.
- O'Brien PJ, Herschlag D (May 2001). "Functional interrelationships in the alkaline phosphatase superfamily: phosphodiesterase activity of Escherichia coli alkaline phosphatase". Biochemistry. 40 (19): 5691–9. doi:10.1021/bi0028892. PMID 11341834.
- Zhao C, Kumada Y, Imanaka H, Imamura K, Nakanishi K (June 2006). "Cloning, overexpression, purification, and characterization of O-acetylserine sulfhydrylase-B from Escherichia coli". Protein Expression and Purification. 47 (2): 607–13. doi:10.1016/j.pep.2006.01.002. PMID 16546401.
- Tokuriki N, Tawfik DS (October 2009). "Stability effects of mutations and protein evolvability". Current Opinion in Structural Biology. 19 (5): 596–604. doi:10.1016/j.sbi.2009.08.003. PMID 19765975.
- Daumann LJ, McCarthy BY, Hadler KS, Murray TP, Gahan LR, Larrabee JA, Ollis DL, Schenk G (January 2013). "Promiscuity comes at a price: catalytic versatility vs efficiency in different metal ion derivatives of the potential bioremediator GpdQ". Biochimica et Biophysica Acta. 1834 (1): 425–32. doi:10.1016/j.bbapap.2012.02.004. PMID 22366468.
- Schmidt DM, Mundorff EC, Dojka M, Bermudez E, Ness JE, Govindarajan S, Babbitt PC, Minshull J, Gerlt JA (July 2003). "Evolutionary potential of (beta/alpha)8-barrels: functional promiscuity produced by single substitutions in the enolase superfamily". Biochemistry. 42 (28): 8387–93. doi:10.1021/bi034769a. PMID 12859183.
- Yoshikuni Y, Ferrin TE, Keasling JD (April 2006). "Designed divergent evolution of enzyme function". Nature. 440 (7087): 1078–82. Bibcode:2006Natur.440.1078Y. doi:10.1038/nature04607. PMID 16495946.
- Ma W, Tang C, Lai L (August 2005). "Specificity of trypsin and chymotrypsin: loop-motion-controlled dynamic correlation as a determinant". Biophysical Journal. 89 (2): 1183–93. arXiv:q-bio/0505037. Bibcode:2005BpJ....89.1183M. doi:10.1529/biophysj.104.057158. PMC 1366603. PMID 15923233.
- Yasutake Y, Yao M, Sakai N, Kirita T, Tanaka I (November 2004). "Crystal structure of the Pyrococcus horikoshii isopropylmalate isomerase small subunit provides insight into the dual substrate specificity of the enzyme". Journal of Molecular Biology. 344 (2): 325–33. doi:10.1016/j.jmb.2004.09.035. PMID 15522288.
- Perona JJ, Hadd A (November 2012). "Structural diversity and protein engineering of the aminoacyl-tRNA synthetases". Biochemistry. 51 (44): 8705–29. doi:10.1021/bi301180x. PMID 23075299.
- Villiers BR, Hollfelder F (March 2009). "Mapping the limits of substrate specificity of the adenylation domain of TycA". Chembiochem. 10 (4): 671–82. doi:10.1002/cbic.200800553. PMID 19189362.
- Vasu K, Nagamalleswari E, Nagaraja V (May 2012). "Promiscuous restriction is a cellular defense strategy that confers fitness advantage to bacteria". Proceedings of the National Academy of Sciences of the United States of America. 109 (20): E1287–93. Bibcode:2012PNAS..109E1287V. doi:10.1073/pnas.1119226109. PMC 3356625. PMID 22509013.
- Weng JK, Philippe RN, Noel JP (June 2012). "The rise of chemodiversity in plants". Science. 336 (6089): 1667–70. Bibcode:2012Sci...336.1667W. doi:10.1126/science.1217411. PMID 22745420.
- Bornscheuer UT, Huisman GW, Kazlauskas RJ, Lutz S, Moore JC, Robins K (May 2012). "Engineering the third wave of biocatalysis". Nature. 485 (7397): 185–94. Bibcode:2012Natur.485..185B. doi:10.1038/nature11117. PMID 22575958.
- Shin JS, Kim BG (August 2001). "Comparison of the omega-transaminases from different microorganisms and application to production of chiral amines". Bioscience, Biotechnology, and Biochemistry. 65 (8): 1782–8. doi:10.1271/bbb.65.1782. PMID 11577718.
- http://www.codexis.com/pdf/Codexis_EnzymePlatforms.pdf[permanent dead link]
- Maier TH (April 2003). "Semisynthetic production of unnatural L-alpha-amino acids by metabolic engineering of the cysteine-biosynthetic pathway". Nature Biotechnology. 21 (4): 422–7. doi:10.1038/nbt807. PMID 12640465.
- Rahman SA, Cuesta SM, Furnham N, Holliday GL, Thornton JM (February 2014). "EC-BLAST: a tool to automatically search and compare enzyme reactions". Nature Methods. 11 (2): 171–4. doi:10.1038/nmeth.2803. PMC 4122987. PMID 24412978.
- Jakoby WB, Ziegler DM (December 1990). "The enzymes of detoxication". The Journal of Biological Chemistry. 265 (34): 20715–8. PMID 2249981.
- "promiscuity". Oxford English Dictionary (3rd ed.). Oxford University Press. September 2005. (Subscription or UK public library membership required.)